Charter Growth Capital is pleased to share an exciting leadership transition at portfolio company Grand River Aseptic Manufacturing (GRAM). On September 1, Denis Johnson, a seasoned executive with more than 25 years of industry experience, was appointed Chief Executive Officer.

Johnson’s appointment comes at a pivotal time as GRAM continues to expand its capabilities to meet growing demand in the global injectable drug market. The company is currently developing a $100 million, 150,000-square-foot syringe and cartridge filling facility in Caledonia Township, expected to open in late 2025. The facility will add four production lines, further enhancing GRAM’s ability to serve pharmaceutical and biotech clients.

With multiple FDA-approved filling lines already in place, GRAM is well positioned to support the industry’s rapid growth, driven by increased demand for biologics and treatments for chronic disease. Under Johnson’s leadership, the company is poised to continue building on its track record of strong growth and operational excellence.

Charter Growth Capital congratulates Denis Johnson and the entire GRAM team on this important milestone and looks forward to supporting the company’s next phase of growth.

Read more here.

‍